Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP870716.RAF_5A8E14NDpgLdefyDz4dI-ph2vi8Ms4e89VuTv7tpo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP870716.RAF_5A8E14NDpgLdefyDz4dI-ph2vi8Ms4e89VuTv7tpo130_assertion type Assertion NP870716.RAF_5A8E14NDpgLdefyDz4dI-ph2vi8Ms4e89VuTv7tpo130_head.
- NP870716.RAF_5A8E14NDpgLdefyDz4dI-ph2vi8Ms4e89VuTv7tpo130_assertion description "[These results contribute to a deeper understanding of the properties of transgenic lymphocytes used to treat human malignancies and may provide a rationale for the development of combination therapies as a method to improve ACT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870716.RAF_5A8E14NDpgLdefyDz4dI-ph2vi8Ms4e89VuTv7tpo130_provenance.
- NP870716.RAF_5A8E14NDpgLdefyDz4dI-ph2vi8Ms4e89VuTv7tpo130_assertion evidence source_evidence_literature NP870716.RAF_5A8E14NDpgLdefyDz4dI-ph2vi8Ms4e89VuTv7tpo130_provenance.
- NP870716.RAF_5A8E14NDpgLdefyDz4dI-ph2vi8Ms4e89VuTv7tpo130_assertion SIO_000772 23861247 NP870716.RAF_5A8E14NDpgLdefyDz4dI-ph2vi8Ms4e89VuTv7tpo130_provenance.
- NP870716.RAF_5A8E14NDpgLdefyDz4dI-ph2vi8Ms4e89VuTv7tpo130_assertion wasDerivedFrom befree-20140225 NP870716.RAF_5A8E14NDpgLdefyDz4dI-ph2vi8Ms4e89VuTv7tpo130_provenance.
- NP870716.RAF_5A8E14NDpgLdefyDz4dI-ph2vi8Ms4e89VuTv7tpo130_assertion wasGeneratedBy ECO_0000203 NP870716.RAF_5A8E14NDpgLdefyDz4dI-ph2vi8Ms4e89VuTv7tpo130_provenance.